Since brain atrophy would be farther down the cascade than neuropathological changes including the spread of beta-amyloid and tau in the brain, it is possible that a different pattern results in this downstream measure compared to more immediate neuropathology effects. The gene discussed is MAPT; the disease is Brain atrophy.